2026

Grabar S, Lakrout P, Potard V, Belot A, Cadranel J, Jacomet C, Katlama C, Marshall E, Lambotte O, Palich R, Ronot-Bregigeon S, Spano J-P, Bouvier A-M, Makinson A, Costagliola D. Cancer risks and trends between 1997-2018, and effects of restored immunity in people living with HIV. Results from the ANRS CO4 French Hospital Database on HIV Int J Cancer. 2025.

Pantazis N, Sabin C, Costagliola D, Grabar S, Carlander C, Gill J, van Sighem A, Jarrin I, Meyer L, Ruiz-Burga E, Tariq S, Spire B, Burns F, Touloumi G, for CC. Temporal trends in viral SetPoint and peak CD4 cell count soon after HIV-1 seroconversion. AIDS. 2026;40(9):1346-54.

Mafuta C, Grabar S, Lievre L, Tran L, Lambotte O, Goujard C, Lacombe K, Robineau O, Meyer L, Seng R, Abgrall S. Factors associated with loss to follow-up among people living with HIV in France. AIDS. 2026;40(9):1376-87.

Hemery J, Tattevin P, Marshall E, Annequin M, Chiarabini T, Dournon N, Maresca AF, Ghosn J, Isernia V, Michard F, Perrineau S, Rincon G, Rouveix E, Spire B, de Truchis P, Grabar S. The HIV care continuum and determinants of antiretroviral therapy initiation among transgender women in France (1997-2023): a longitudinal cohort study. Lancet Reg Health Eur. 2026;69:101820.

Grabar S, Makinson A, Spano J-P, Costagliola D. Les risques de cancer chez les personnes vivant avec le VIH : une normalisation incomplète à l’ère des traitements efficaces. Résultats de la cohorte hospitalière sur l’infection à VIH (ANRS CO4 FHDH). Médecine/Sciences. 2026;42(8-9):687-90.

Mafuta C, Grabar S, Lievre L, Goujard C, Viard JP, Bouchaud O, Meyer L, Seng R, Abgrall S. Psychosocial vulnerabilities and loss to follow-up in people living with HIV in France. HIV Med. 2026 Oct;27(10):1682-1697. doi: 10.1111/hiv.70293. Epub 2026 Aug 13.